Leflunomide for relapsing polychondritis: successful longterm treatment.
Handler
Richard P
RP
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D002097:C-Reactive Protein / Q000378:metabolism; D002792:Cholestyramine Resin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000077339:Leflunomide; D007958:Leukocyte Count; D007964:Leukocytosis / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D020795:Photophobia / Q000139:chemically induced*; D010976:Platelet Count; D011081:Polychondritis, Relapsing / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D013922:Thrombocytosis / Q000139:chemically induced*; D017211:Treatment Failure
D000893:Anti-Inflammatory Agents; D007555:Isoxazoles; D002792:Cholestyramine Resin; D002097:C-Reactive Protein; D000077339:Leflunomide